Follow
Katherine Stefanski
Katherine Stefanski
Verified email at vanderbilt.edu
Title
Cited by
Cited by
Year
A novel pH-dependent membrane peptide that binds to EphA2 and inhibits cell migration
DS Alves, JM Westerfield, X Shi, VP Nguyen, KM Stefanski, KR Booth, ...
Elife 7, e36645, 2018
412018
Development of a Lac Operon Concept Inventory (LOCI)
KM Stefanski, GE Gardner, RL Seipelt-Thiemann
CBE—Life Sciences Education 15 (2), ar24, 2016
272016
PIP2 promotes conformation-specific dimerization of the EphA2 membrane region
KM Stefanski, CM Russell, JM Westerfield, R Lamichhane, FN Barrera
Journal of Biological Chemistry 296, 2021
252021
High-content imaging platform to discover chemical modulators of plasma membrane rafts
N Fricke, K Raghunathan, A Tiwari, KM Stefanski, M Balakrishnan, ...
ACS Central Science 8 (3), 370-378, 2022
102022
How T118M peripheral myelin protein 22 predisposes humans to Charcot–Marie–Tooth disease
KM Stefanski, GC Li, JT Marinko, BD Carter, DC Samuels, CR Sanders
Journal of Biological Chemistry 299 (2), 2023
42023
The use of a hands-on model in learning the regulation of an inducible operon and the development of a gene regulation concept inventory
KM Stefanski
Middle Tennessee State University, 2015
22015
Altering protein function by pharmacological targeting of membrane domains
AK Kenworthy, N Fricke, A Tiwari, CR Sanders, K Raghunathan, H Huang, ...
US Patent App. 18/273,728, 2024
2024
Reply to Record et al.“The role of PMP22 T118M in Charcot–Marie–Tooth disease remains unsolved”
KM Stefanski, GC Li, JT Marinko, BD Carter, DC Samuels, CR Sanders
Journal of Biological Chemistry 299 (10), 2023
2023
High-throughput screening to identify modulators of membrane protein raft affinity in giant plasma membrane vesicles
KM Stefanski, J Bauer, AK Kenworthy, CR Sanders
Biophysical Journal 122 (3), 449a, 2023
2023
Protein Phase Separation in Biomolecular Condensates High-Throughput Screening to Identify Modulators of Raft Formation and Membrane Protein Raft Affinity in Giant Plasma …
K Stefanski, H Huang, J Bauer, A Kenworthy, C Sanders
PROTEIN SCIENCE 32, 2023
2023
Track: Integrating Techniques to Address Challenges in Protein Structural Biology Elucidating the Unusual Disease-Predisposing T118M Variant of Peripheral Myelin Protein 22
G Li, K Stefanski, J Marinko, C Sanders
PROTEIN SCIENCE 32, 2023
2023
Towards Improved Cell Culture Models of Type 1 Charcot-Marie-Tooth Disease
M Wilkinson, K Stefanski, P Gowda, B Carter, C Sanders
PROTEIN SCIENCE 32, 2023
2023
PIP2 Promotes Conformation-Specific Dimerization of the EPHA2 Transmembrane Domain through Juxtamembrane Interactions
KM Stefanski, CM Russeull, JM Westerfield, R Lamichhane, FN Barrera
Biophysical Journal 120 (3), 287a, 2021
2021
Topology-Switching Membrane Peptides for Determination of the Active Transmembrane Dimer Interface of the Epha2 Receptor
JM Westerfield, A Sahoo, J Schuster, KM Stefanski, A Cameron, ...
Biophysical Journal 120 (3), 133a, 2021
2021
Transmembrane and Juxtamembrane Interactions of EphA2 with Lipid Membranes in the Active and Inactive States
KM Stefanski, JM Westerfield, FN Barrera
Biophysical Journal 118 (3), 240a, 2020
2020
Investigating transmembrane-lipid interactions of EphA2 and pH responsive peptides
KM Stefanski
2020
A Conditional Transmembrane Peptide Inhibits Cell Migration by Activation of the EphA2 Receptor Tyrosine Kinase
DS Alves, JM Westerfield, X Shi, VP Nguyen, KM Stefanski, AW Smith, ...
Biophysical Journal 116 (3), 176a, 2019
2019
TYPE7: a novel peptide that interacts with EphA2 receptor and reduces cell migration.
DS Alves, JM Westerfield, X Shi, VP Nguyen, KM Stefanski, AW Smith, ...
MOLECULAR BIOLOGY OF THE CELL 29 (26), 2018
2018
A Novel Membrane Peptide that Inhibits Cell Migration by Activation of the Receptor Tyrosine Kinase EphA2
JM Westerfield, DS Alves, X Shi, VP Nguyen, RH Pullen, KM Stefanski, ...
Biophysical Journal 114 (3), 265a, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–19